Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591486 | SCV000707499 | uncertain significance | not provided | 2017-04-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000591486 | SCV002210458 | likely benign | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532570 | SCV003587945 | uncertain significance | Inborn genetic diseases | 2021-12-07 | criteria provided, single submitter | clinical testing | The c.2543G>A (p.G848E) alteration is located in exon 13 (coding exon 13) of the ADGRV1 gene. This alteration results from a G to A substitution at nucleotide position 2543, causing the glycine (G) at amino acid position 848 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |